Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
Scientific Industries (OTCQB: SCND) has secured $1.6 million in private placement funding to advance its SBI's DOTS Platform, a real-time bioprocessing system. The offering includes 1,550,000 shares of common stock at $1.00 per share, with each share including a warrant to purchase an additional share at $1.00 within six months.
The company plans to launch its first-in-class optical pH sensor and high-performance liquid injection system in the second half of 2025. The DOTS MPS platform aims to establish a new standard in parallel bioprocessing for AI and digital biology applications, providing affordable, structured, reliable, and repeatable data for shake flask research.
Brookline Capital Markets, a division of Arcadia Securities, , served as the exclusive placement agent for the offering.
Scientific Industries (OTCQB: SCND) ha ottenuto 1,6 milioni di dollari tramite un collocamento privato per sviluppare la piattaforma DOTS di SBI, un sistema di bioprocessi in tempo reale. L'offerta comprende 1.550.000 azioni ordinarie a 1,00 dollaro ciascuna, con ogni azione che include un warrant per acquistare un'ulteriore azione a 1,00 dollaro entro sei mesi.
L'azienda prevede di lanciare il suo sensore ottico pH di prima classe e il sistema di iniezione liquida ad alte prestazioni nella seconda metà del 2025. La piattaforma DOTS MPS mira a stabilire un nuovo standard nel bioprocesso parallelo per applicazioni di intelligenza artificiale e biologia digitale, offrendo dati accessibili, strutturati, affidabili e replicabili per la ricerca con flask agitati.
Brookline Capital Markets, una divisione di Arcadia Securities, ha agito come agente esclusivo per il collocamento.
Scientific Industries (OTCQB: SCND) ha asegurado 1,6 millones de dólares en financiamiento mediante colocación privada para avanzar en la plataforma DOTS de SBI, un sistema de bioprocesamiento en tiempo real. La oferta incluye 1.550.000 acciones ordinarias a 1,00 dólar por acción, con cada acción que incluye un warrant para comprar una acción adicional a 1,00 dólar dentro de seis meses.
La compañía planea lanzar su sensor óptico de pH de primera clase y un sistema de inyección líquida de alto rendimiento en la segunda mitad de 2025. La plataforma DOTS MPS busca establecer un nuevo estándar en bioprocesamiento paralelo para aplicaciones de inteligencia artificial y biología digital, proporcionando datos accesibles, estructurados, confiables y repetibles para la investigación con matraces agitados.
Brookline Capital Markets, una división de Arcadia Securities, actuó como agente exclusivo de colocación para la oferta.
Scientific Industries (OTCQB: SCND)는 SBI의 DOTS 플랫폼, 실시간 생물처리 시스템을 발전시키기 위해 160만 달러의 사모 펀딩을 확보했습니다. 이번 공모에는 주당 1.00달러에 1,550,000주의 보통주가 포함되며, 각 주식에는 6개월 이내에 추가 주식을 1.00달러에 구매할 수 있는 워런트가 포함되어 있습니다.
회사는 2025년 하반기에 첫 번째 광학 pH 센서와 고성능 액체 주입 시스템을 출시할 계획입니다. DOTS MPS 플랫폼은 AI 및 디지털 생물학 응용을 위한 병렬 생물처리의 새로운 표준을 확립하여 흔들리는 플라스크 연구에 저렴하고 구조화되며 신뢰할 수 있고 반복 가능한 데이터를 제공하는 것을 목표로 합니다.
Brookline Capital Markets, Arcadia Securities의 한 부서가 이번 공모의 독점 배치 대행사로 활동했습니다.
Scientific Industries (OTCQB : SCND) a obtenu un financement de 1,6 million de dollars via un placement privé pour faire avancer la plateforme DOTS de SBI, un système de bioprocédés en temps réel. L'offre comprend 1 550 000 actions ordinaires au prix de 1,00 dollar par action, chaque action incluant un bon de souscription permettant d'acheter une action supplémentaire à 1,00 dollar dans un délai de six mois.
L'entreprise prévoit de lancer son capteur optique de pH de première classe et son système d'injection liquide haute performance au second semestre 2025. La plateforme DOTS MPS vise à établir une nouvelle norme dans le bioprocédé parallèle pour les applications d'IA et de biologie numérique, fournissant des données abordables, structurées, fiables et reproductibles pour la recherche en flacons agités.
Brookline Capital Markets, une division d'Arcadia Securities, a agi en tant qu'agent exclusif pour ce placement.
Scientific Industries (OTCQB: SCND) hat 1,6 Millionen US-Dollar durch eine Privatplatzierung gesichert, um die DOTS-Plattform von SBI, ein Echtzeit-Bioprozesssystem, voranzutreiben. Das Angebot umfasst 1.550.000 Stammaktien zu je 1,00 US-Dollar, wobei jede Aktie einen Warrant enthält, der den Kauf einer weiteren Aktie zu 1,00 US-Dollar innerhalb von sechs Monaten ermöglicht.
Das Unternehmen plant, in der zweiten Hälfte des Jahres 2025 seinen erstklassigen optischen pH-Sensor und das Hochleistungs-Flüssigkeitseinspritzsystem auf den Markt zu bringen. Die DOTS MPS-Plattform soll einen neuen Standard im parallelen Bioprozess für KI- und digitale Biologieanwendungen setzen und erschwingliche, strukturierte, zuverlässige und reproduzierbare Daten für die Schüttelflaschenforschung liefern.
Brookline Capital Markets, eine Division von Arcadia Securities, fungierte als exklusiver Platzierungsagent für das Angebot.
- Secured $1.6 million in new funding
- Upcoming launch of innovative bioprocessing products in H2 2025
- Warrant offering provides potential for additional capital within 6 months
- Dilutive effect of 1.55 million new shares issuance
- Below-market pricing of shares at $1.00
BOHEMIA, N.Y., April 22, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it has successfully secured approximately
The offering consisted of 1,550,000 shares of the Company’s common stock at a purchase price of
John Moore, Chairman, said, “We appreciate the continued support of our longstanding shareholders as we scale our DOTS platform with the upcoming launch of our first-in-class optical pH sensor and high-performance liquid injection system in the second half of 2025. With DOTS MPS, we’re creating the standard in parallel bioprocessing to power the next era of AI and digital biology. AI run on data and DOTS delivers affordable, structured, reliable, and repeatable data for the first time in shake flask, science’s most widely used reaction vessel.”
Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as the exclusive placement agent for the offering.
This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security and does not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful.
About Scientific Industries, Inc.
Scientific Industries (OTCQB: SCND), is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems under the product name DOTS. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com.
About Scientific Bioprocessing, Inc.
Scientific Bioprocessing, Inc. (“SBI”) is dedicated to pioneering digitally simplified bioprocessing by providing actionable insights from lab to production floor. With a broad portfolio of state-of-the-art bioprocess sensors and actuators as well as innovative data analytics software, SBI helps scientists and engineers in bioprocessing to monitor and control critical process parameters and product quality attributes. SBI is a subsidiary of Scientific Industries Inc. (OTCQB: SCND). To learn more, visit www.scientificbio.com.
Safe Harbor Statement
Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.
| Company Contact: | |
| Helena R. Santos CEO and President Phone: 631-567-4700 hsantos@scientificindustries.com info@scientificindustries.com | or: Joe Dorame Lytham Partners, LLC Phone: (602)889-9700 SCND@lythampartners.com |
FAQ
What is the size and terms of Scientific Industries' (SCND) recent private placement?
When will Scientific Industries (SCND) launch its new DOTS platform products?
How will the DOTS platform benefit AI and digital biology research?
What is the purpose of Scientific Industries' (SCND) recent funding round?
